Dendritic cell recruitment by the chemokine XCL1 improves cancer outcomes
Posted by Brian Volkman on 9/8/2023 to
Literature Highlights
XCL1 as a Potential Biomarker to Predict Durable Response to Anti-PD-1 Treatment in Non-Small Cell Lung Cancer XCL1 is secreted by activated T and NK cells. It is thought to function by promoting their engagement with antigen-presenting